Table 2.

Patient’s profile before ADSVCs injection

Patient’s initials	Age, yrs	Gender, M/F	Diameter preoperatively (μ)	Density preoperatively (h/cm2)	Pull test	Number of cells × 106 injected/ 25 spots	Cell viability (%)	Apoptotic index (%)	Telomerase test
NM	23	F	72	72	5	4.20	99.51	0.32	Negative
AR	25	F	67	37	4	4.31	96.32	3.21	Negative
CK	27	F	72	98	2	4.32	99.02	1.00	Negative
ZS	37	F	66	134	3	4.19	99.14	0.98	Negative
RC	38	F	63	65	3	4.30	98.27	1.62	Negative
WK	43	F	64	43	4	4.49	99.82	0.44	Negative
GC	54	F	70	143	6	4.08	99.05	0.36	Negative
AM	56	F	60	30	4	4.70	96.42	3.11	Negative
MM	63	F	68	160	6	4.60	99.55	0.03	Negative
FR	27	M	65	66	2	4.58	98.28	1.09	Negative
MB	32	M	50	34	3	4.35	99.11	0.45	Negative
RO	32	M	48	127	5	4.22	99.73	0.16	Negative
SF	32	M	63	157	3	4.03	99.56	0.33	Negative
IA	34	M	57	113	5	4.46	99.70	0.37	Negative
SH	36	M	56	97	6	4.01	99.52	0.44	Negative
PC	37	M	63	65	4	4.50	99.58	0.61	Negative
HB	38	M	54	101	5	4.70	99.63	0.55	Negative
TB	38	M	56	88	8	4.22	99.59	0.11	Negative
OC	43	M	56	76	4	4.07	99.00	0.28	Negative
MH	51	M	41	68	5	4.26	99.81	0.24	Negative

Diameter: fine hair ≤ 60 μ; medium hair 60 to 80 μ, good hair ≥ 80 μ; Density: quantity of hair per cm², normal is 175 to 300 hair/cm²; Pull test is the quantity of hair pulled with the finger pull test, normal is zero. 0.2 ml per spot of injection was delivered perpendicularly, separated by 1 cm in a square shape all over the scalp and a total of 5 ml were injected in 25 spots. Cell viability and apoptotic index as assessed by labeled cells with Annexin V/propidium iodide (PI)/7AAD, are expressed respectively as the percentage of Annexin V⁽⁻⁾/PI⁽⁻⁾/7AAD⁽⁻⁾ or Annexin V⁽⁺⁾ cells divided by total cells

ADSVCs adipose-derived stromal vascular cells